NAGE: Niagen Bioscience, Inc. Common Stock Company Profile & Statistics

Niagen Bioscience, Inc. Common Stock Profile

About

Niagen Bioscience Inc. is a nicotinamide adenine dinucleotide science and healthy-aging research company. Niagen Bioscience Inc., formerly known as ChromaDex Corp., is based in LOS ANGELES.

Info & Links

CEO

Robert Fried

Headquarters

10900 Wilshire Blvd. Suite 600
Los Angeles, CA 90024, UNITED STATES

Auditor

Crowe LLP

Share holders

Employees

104

Niagen Bioscience, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

521.61M

Enterprise Value

457.32M

Enterprise Value/EBITDA(ttm)

22.78

Price to Earnings Ratio(ttm)

39.62

Price to Sales(ttm)

4.06

Price to Book(mrq)

7.15

Price to Cash(ytd)

107.19

Profitability

Gross Margin(ttm)

63.85%

Operating Margin(ttm)

11.43%

Profit Margin(ttm)

16.58%

Return on Equity(ttm)

24.13%

Return on Invested Capital(ttm)

36.82%

Return on Assets(ttm)

16.81%

Income Statement

Revenue(ttm)

124.71M

Revenue Per Share(ttm)

1.56

Gross Profit(ttm)

79.68M

EBITDA(ttm)³

20.08M

Net Income Available to Common(ttm)

20.43M

Diluted EPS(ttm)

0.24

Share Statistics

Beta (5Y Monthly)

2.31

52-Week Change

S&P 500 52-Week Change

15.47%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

79.81M

Dividend Yield

0.00%

Float⁴

72.31M

% Held by Insiders

9.39%

% Held by Institutions

15.41%

Balance Sheet

Total Cash(mrq)

64.29M

Total Cash Per Share(mrq)

0.81

Total Debt(mrq)

2.00K

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.12%

Quick Ratio(mrq)

3.29%

Book Value Per Share(mrq)

0.89

Cash Flow

Operating Cash Flow Per Share(ytd)

0.15

Free Cash Flow(ytd)

12.63M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NAGE

Niagen Bioscience, Inc. Common Stock